Despite advances in wound treatment through tissue engineering, the rapid colonization of biomaterials by host cells remains a crucial step toward complete wound healing. Thanks to their excellent biocompatibility, biodegradability, low antigenicity and cost-effectiveness, cross-linked hydrogels have attracted much attention as a viable solution for wound treatment. In this work, we have developed an inovative cross-linking method for gelatin-based hydrogels inspired by the wound closure mechanism of the green algae Caulerpa taxifolia . Caulerpenyne (CYN), a metabolite extracted from the algae, was used as a latent cross-linking agent for gelatin. The covalent cross-linking process is triggered by an in situ and on-demand deacetylation of the enol acetate functionalities of CYN in oxytoxin 2 (OXY) containing 1,4-dialdehyde, which immediately reacts with the lysine residue in gelatin. The content of ε-amino groups in gelatin was monitored as a function of CYN concentration. Swelling and gel content were analyzed as a function of CYN concentration. Morphology, rheological and biological properties were evaluated by in vitro and in vivo tests. Cell adhesion and viability tests performed with OXY-cross-linked hydrogels and compared with non-cross-linked and genipin-cross-linked gelatin showed excellent performance. Their use in whole skin wounds in pigs showed that CYN-cross-linked hydrogels promoted complete skin regeneration without any cytotoxicity, making them extremely promising matrices in the field of regenerative medicine.
No takes yet. Share an insight, caveat, or question.
Melilli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: